Brind.

Edwards reported on the international performance of its SAPIEN3 Ultra RESILIA and TAVR arm products, noting expansion in Europe and strong performance in the US.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Edwards reported on the international performance of its SAPIEN3 Ultra RESILIA and TAVR arm products, noting expansion in Europe and strong performance in the US.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksRobust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings Edwards Lifesciences Corp. EW is scheduled to report second-quarter 2025 results on July 24, after market close. In the last reported qua